0001179110-21-005767.txt : 20210521
0001179110-21-005767.hdr.sgml : 20210521
20210521205744
ACCESSION NUMBER: 0001179110-21-005767
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210519
FILED AS OF DATE: 20210521
DATE AS OF CHANGE: 20210521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katkin Keith
CENTRAL INDEX KEY: 0001314596
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 21950893
MAIL ADDRESS:
STREET 1: C/O UROVANT SCIENCES, INC.
STREET 2: 5281 CALIFORNIA AVENUE, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
MAIL ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2021-05-19
0
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001314596
Katkin Keith
C/O RIGEL PHARMACEUTICALS, INC.
1180 VETERANS BLVD.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2021-05-19
4
A
0
25000
0
A
25000
D
Stock Option (Right to Buy)
3.64
2021-05-19
4
A
0
30000
0
A
2031-05-19
Common Stock
30000
30000
D
The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the reporting person's continuous service on the Company's Board of Directors.
The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors.
/s/ Dolly Vance (Attorney-in-Fact)
2021-05-21